Physician profile
Jay N Wright
NPI 1265537476
$3,413.47
in general payments reported to CMS, 2019-2025
27 companies · $314 in 2025
The $314 reported for 2025 was less than what a typical Pain Medicine provider received nationally (typical 2025 total: $515).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $517 · 2020: $539 · 2021: $462 · 2022: $436 · 2023: $685 · 2024: $460 · 2025: $314.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,459.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,458.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $1,278.75 | 2019-2025 | Xtampza, Belbuca |
| Nevro Corp. | $449.97 | 2020-2024 | Senza |
| Medtronic, INC. | $243.61 | 2023-2024 | Intellis Adaptivestim |
| Amgen INC. | $157.81 | 2019-2022 | |
| Scilex Pharmaceuticals INC. | $151.03 | 2021-2023 | Ztlido |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $147.75 | 2019-2025 | Relistor |
| Boston Scientific Corporation | $136.27 | 2019-2025 | General - Pain Management |
| Pfizer INC. | $106.97 | 2019-2021 | |
| Si-Bone, INC. | $92.45 | 2019 | |
| Medtronic USA, INC. | $90.83 | 2019-2020 | |
| Abbott Laboratories | $86.91 | 2020-2025 | Eterna |
| Globus Medical, INC. | $64.61 | 2025 | Senza |
| Radius Health, INC. | $52.38 | 2020-2021 | |
| Kowa Pharmaceuticals America, INC. | $48.97 | 2022-2023 | Seglentis |
| Bioventus LLC | $48.87 | 2019-2021 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Protega Pharmaceutials INC | $37.00 | 2025 | Roxybond |
| Ferring Pharmaceuticals INC. | $35.23 | 2019 | |
| Pacira Therapeutics, INC. | $29.48 | 2020-2021 | |
| Stimwave Technologies Incorporated | $23.00 | 2019 | |
| Horizon Therapeutics Plc | $22.86 | 2021 | |
| Zimmer Biomet Holdings, INC. | $21.06 | 2019 | |
| Averitas Pharma INC. | $16.23 | 2025 | Qutenza |
| Janssen Pharmaceuticals, INC | $15.62 | 2023 | Xarelto |
| Shionogi INC | $15.46 | 2019 | |
| Eisai INC. | $14.44 | 2021 | |
| Idorsia Pharmaceuticals US INC | $13.34 | 2023 | Quviviq |
| Astrazeneca Pharmaceuticals Lp | $12.57 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.